118 related articles for article (PubMed ID: 9762921)
1. NMDA-receptor antagonist requirements in conantokin-G.
Blandl T; Prorok M; Castellino FJ
FEBS Lett; 1998 Sep; 435(2-3):257-62. PubMed ID: 9762921
[TBL] [Abstract][Full Text] [Related]
2. The roles of individual gamma-carboxyglutamate residues in the solution structure and cation-dependent properties of conantokin-T.
Warder SE; Prorok M; Chen Z; Li L; Zhu Y; Pedersen LG; Ni F; Castellino FJ
J Biol Chem; 1998 Mar; 273(13):7512-22. PubMed ID: 9516452
[TBL] [Abstract][Full Text] [Related]
3. Binding of cations to individual gamma-carboxyglutamate residues of conantokin-G and conantokin-T.
Blandl T; Warder SE; Prorok M; Castellino FJ
J Pept Res; 1999 Apr; 53(4):453-64. PubMed ID: 10406223
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
[TBL] [Abstract][Full Text] [Related]
5. Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R.
Blandl T; Zajicek J; Prorok M; Castellino FJ
J Biol Chem; 2001 Mar; 276(10):7391-6. PubMed ID: 11096077
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site.
Zhou LM; Szendrei GI; Fossom LH; Maccecchini ML; Skolnick P; Otvos L
J Neurochem; 1996 Feb; 66(2):620-8. PubMed ID: 8592132
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes in conantokin-G induced upon binding of calcium and magnesium as revealed by NMR structural analysis.
Chen Z; Blandl T; Prorok M; Warder SE; Li L; Zhu Y; Pedersen LG; Ni F; Castellino FJ
J Biol Chem; 1998 Jun; 273(26):16248-58. PubMed ID: 9632684
[TBL] [Abstract][Full Text] [Related]
8. Amino acid determinants for NMDA receptor inhibition by conantokin-T.
Warder SE; Blandl T; Klein RC; Castellino FJ; Prorok M
J Neurochem; 2001 May; 77(3):812-22. PubMed ID: 11331410
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MK801 binding in adult rat brain sections by conantokin-G and conantokin-T.
Klein RC; Castellino FJ
Neurosci Lett; 1999 Oct; 273(3):171-4. PubMed ID: 10515186
[TBL] [Abstract][Full Text] [Related]
10. Structure-function relationships of the NMDA receptor antagonist peptide, conantokin-R.
Blandl T; Warder SE; Prorok M; Castellino FJ
FEBS Lett; 2000 Mar; 470(2):139-46. PubMed ID: 10734223
[TBL] [Abstract][Full Text] [Related]
11. Calcium binding properties of synthetic gamma-carboxyglutamic acid-containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T.
Prorok M; Warder SE; Blandl T; Castellino FJ
Biochemistry; 1996 Dec; 35(51):16528-34. PubMed ID: 8987986
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamics of binding of calcium, magnesium, and zinc to the N-methyl-D-aspartate receptor ion channel peptidic inhibitors, conantokin-G and conantokin-T.
Prorok M; Castellino FJ
J Biol Chem; 1998 Jul; 273(31):19573-8. PubMed ID: 9677382
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides.
Klein RC; Warder SE; Galdzicki Z; Castellino FJ; Prorok M
Neuropharmacology; 2001 Dec; 41(7):801-10. PubMed ID: 11684144
[TBL] [Abstract][Full Text] [Related]
14. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
Klein RC; Prorok M; Galdzicki Z; Castellino FJ
J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
[TBL] [Abstract][Full Text] [Related]
15. Direct binding properties of conantokins to native N-methyl-d-aspartate receptors.
Klein RC; Prorok M; Castellino FJ
J Pept Res; 2003 Jun; 61(6):307-17. PubMed ID: 12753378
[TBL] [Abstract][Full Text] [Related]
16. Metal-ion-binding properties of synthetic conantokin-G.
Blandl T; Zajicek J; Prorok M; Castellino FJ
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):777-83. PubMed ID: 9396720
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
Klein RC; Galdzicki Z; Castellino FJ
Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277
[TBL] [Abstract][Full Text] [Related]
18. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
Wittekindt B; Malany S; Schemm R; Otvos L; Maccecchini ML; Laube B; Betz H
Neuropharmacology; 2001 Nov; 41(6):753-61. PubMed ID: 11640930
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-d-aspartate Receptors.
Kunda S; Yuan Y; Balsara RD; Zajicek J; Castellino FJ
J Biol Chem; 2015 Jul; 290(29):18156-18172. PubMed ID: 26048991
[TBL] [Abstract][Full Text] [Related]
20. The NMR solution structure of the NMDA receptor antagonist, conantokin-T, in the absence of divalent metal ions.
Warder SE; Chen Z; Zhu Y; Prorok M; Castellino FJ; Ni F
FEBS Lett; 1997 Jul; 411(1):19-26. PubMed ID: 9247135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
